secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2022-02-02T23:59:59+00:00
Accession:  0000097745-22-000003
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q4 revenue $10.70B, adj EPS $6.54; full-year rev up 22% to $39.21B
--------------------------------------------------------------------------------

- Q4 GAAP diluted EPS $4.17 (vs $6.24); adjusted EPS $6.54 (vs $7.09); COVID-19 response rev $2.45B.
- Full-year GAAP diluted EPS $19.46 (+22%); adjusted EPS $25.13 (+28%); COVID-19 response rev $9.23B.
- Base business organic growth 8% in Q4, 14% for full year; acquisitions added 6% and 3%, respectively.
- Invested $24B in 2021 strategic acquisitions (PPD, PeproTech); returned $2.4B to shareholders via buybacks and dividends.
- 2022 financial guidance to be provided during earnings call; no specific numbers in release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774522000003/0000097745-22-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774522000003/tmo-20220202.htm
  HTML page:      https://secwatch.observer/filing/0000097745-22-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer